Published in Clin J Am Soc Nephrol on July 02, 2008
Effects of phosphate binders in moderate CKD. J Am Soc Nephrol (2012) 2.92
Parathyroidectomy for the attainment of NKF-K/DOQI™ and KDIGO recommended values for bone and mineral metabolism in dialysis patients with uncontrollable secondary hyperparathyroidism. Langenbecks Arch Surg (2012) 1.02
CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis. Clin J Am Soc Nephrol (2013) 0.95
Decreases in PTH in Japanese hemodialysis patients with secondary hyperparathyroidism: associations with changing practice patterns. Clin J Am Soc Nephrol (2011) 0.86
Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction. Clin Kidney J (2013) 0.86
Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients--results of the Austrian cohort of the ECHO study. Wien Klin Wochenschr (2011) 0.85
Pharmacology of the phosphate binder, lanthanum carbonate. Ren Fail (2011) 0.81
Lanthanum carbonate reduces urine phosphorus excretion: evidence of high-capacity phosphate binding. Ren Fail (2012) 0.81
A New Data Analysis System to Quantify Associations between Biochemical Parameters of Chronic Kidney Disease-Mineral Bone Disease. PLoS One (2016) 0.80
Refining the definition of clinically important mineral and bone disorder in hemodialysis patients. Nephrol Dial Transplant (2015) 0.79
Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients. Am J Nephrol (2016) 0.78
Utilization of parathyroidectomy for secondary hyperparathyroidism in end-stage renal disease. Clin Kidney J (2013) 0.77
Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism? BMC Nephrol (2012) 0.77
Analysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients. Int J Nephrol Renovasc Dis (2014) 0.77
Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis. BMC Nephrol (2016) 0.75
Parathyroid hormone change after cinacalcet initiation and one-year clinical outcome risk: a retrospective cohort study. BMC Nephrol (2015) 0.75
Hidden Hypercalcemia and Mortality Risk in Incident Hemodialysis Patients. J Clin Endocrinol Metab (2016) 0.75
Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis. Health Qual Life Outcomes (2015) 0.75
A comparison of the long-term effects of lanthanum carbonate and calcium carbonate on the course of chronic renal failure in rats with adriamycin-induced nephropathy. PLoS One (2014) 0.75
Prevalence and severity of disordered mineral metabolism in patients with chronic kidney disease: A study from a tertiary care hospital in India. Indian J Endocrinol Metab (2016) 0.75
Propensity score matching and persistence correction to reduce bias in comparative effectiveness: the effect of cinacalcet use on all-cause mortality. Pharmacoepidemiol Drug Saf (2015) 0.75
[Management of secondary hyperparathyroidism-current impact of parathyroidectomy]. Wien Med Wochenschr (2016) 0.75
Chronic Kidney Disease-Mineral and Bone Disorder in Asia. Kidney Dis (Basel) (2017) 0.75
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol (2004) 11.23
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis (1998) 7.79
Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies. Am J Epidemiol (2004) 6.89
Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med (2003) 6.41
Stratification by a multivariate confounder score. Am J Epidemiol (1976) 4.58
Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol (2005) 4.44
Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol (2001) 4.36
Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int (2005) 3.56
Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol (2005) 2.51
Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol (2004) 2.04
Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl. Kidney Int (2005) 1.96
The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients. Am J Kidney Dis (2005) 1.60
Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization? J Am Soc Nephrol (2007) 1.15
Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation. Am J Kidney Dis (2001) 1.12
Achieving K/DOQI laboratory target values for bone and mineral metabolism: an uphill battle. Am J Nephrol (2004) 1.03
Secondary hyperparathyroidism in chronic hemodialysis patients: prevalence and race. Ren Fail (2003) 1.02
Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients. Am J Kidney Dis (2002) 0.90
Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units. Nephrol Dial Transplant (2006) 0.87
On Miettinen's multivariate confounder score. J Clin Epidemiol (1998) 0.86
Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia. J Nephrol (2005) 0.85
Impact of the new K/DOQI guidelines. Blood Purif (2002) 0.84
Twice versus thrice weekly administration of intravenous calcitriol in dialysis patients: a randomized prospective trial. Gruppo Italiano di Studio dell'Osteodistrofia Renale. Clin Nephrol (2000) 0.80
Consequences of the implementation of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease in a population of patients on chronic hemodialysis. J Nephrol (2007) 0.80
Variable selection for propensity score models. Am J Epidemiol (2006) 10.68
A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol (2005) 7.31
The rise and fall of epidemiology, 1950-2000 A.D. 1981. Int J Epidemiol (2007) 4.56
Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol (2005) 3.33
Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. Am J Epidemiol (2010) 2.74
Performance of propensity score calibration--a simulation study. Am J Epidemiol (2007) 2.56
Exploring relative mortality and epoetin alfa dose among hemodialysis patients. Am J Kidney Dis (2008) 2.43
Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile. Pharmacoepidemiol Drug Saf (2006) 2.38
Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care (2007) 2.31
Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs. Pharmacoepidemiol Drug Saf (2013) 2.01
Insights into different results from different causal contrasts in the presence of effect-measure modification. Pharmacoepidemiol Drug Saf (2006) 1.99
The burden of adult asthma in the United States: evidence from the Medical Expenditure Panel Survey. J Allergy Clin Immunol (2011) 1.93
Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies. Hepatology (2006) 1.87
Seasonal variation in hospital discharge diagnosis of atrial fibrillation: a population-based study. Epidemiology (2002) 1.85
One-to-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf (2012) 1.82
Effects of adjusting for instrumental variables on bias and precision of effect estimates. Am J Epidemiol (2011) 1.77
Effect of obesity on the outcome of kidney transplantation: a 20-year follow-up. Transplantation (2011) 1.77
The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration. Pharmacoepidemiol Drug Saf (2011) 1.74
Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy. Am J Epidemiol (2012) 1.68
Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study. BMJ (2011) 1.65
An internet-based prospective study of body size and time-to-pregnancy. Hum Reprod (2009) 1.64
Cohort profile: the Danish Web-based Pregnancy Planning Study--'Snart-Gravid'. Int J Epidemiol (2008) 1.62
A prospective cohort study of physical activity and time to pregnancy. Fertil Steril (2012) 1.58
Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura. Am J Hematol (2009) 1.58
A successful implementation of e-epidemiology: the Danish pregnancy planning study 'Snart-Gravid'. Eur J Epidemiol (2010) 1.57
Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information. Med Care (2007) 1.56
Topiramate use in pregnancy and the birth prevalence of oral clefts. Pharmacoepidemiol Drug Saf (2014) 1.52
Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border. Environ Health Perspect (2006) 1.47
Does relaxed reproductive selection explain the decline in male reproductive health? A new hypothesis. Epidemiology (2002) 1.42
Responses to "Texaco and its consultants": elevating the level of scientific discourse. Int J Occup Environ Health (2005) 1.41
Using prescription claims data for drugs available over-the-counter (OTC). Pharmacoepidemiol Drug Saf (2007) 1.39
Extra scrutiny for industry funded trials. BMJ (2005) 1.38
Update on unethical use of placebos in randomised trials. Bioethics (2003) 1.35
Screening for prostate cancer remains controversial. BMJ (2009) 1.34
Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study. Circulation (2002) 1.32
Obesity and mortality risk among younger dialysis patients. Clin J Am Soc Nephrol (2012) 1.29
Randomized trial of questionnaire length. Epidemiology (2009) 1.27
Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes. CMAJ (2011) 1.26
Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol (2006) 1.21
Age dependence of the relation between reassortant rotavirus vaccine (RotaShield) and intussusception. J Infect Dis (2006) 1.21
Estimation using all available covariate information versus a fixed look-back window for dichotomous covariates. Pharmacoepidemiol Drug Saf (2013) 1.15
Association of Apgar score at five minutes with long-term neurologic disability and cognitive function in a prevalence study of Danish conscripts. BMC Pregnancy Childbirth (2009) 1.15
A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia. J Med Econ (2013) 1.13
Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations. Am J Kidney Dis (2009) 1.07
Postterm delivery and risk for epilepsy in childhood. Pediatrics (2007) 1.04
A prospective cohort study of menstrual characteristics and time to pregnancy. Am J Epidemiol (2011) 1.03
The effect of altitude on dosing and response to erythropoietin in ESRD. J Am Soc Nephrol (2008) 1.00
Applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses. Pharmacoepidemiol Drug Saf (2011) 1.00
Variation in antipsychotic treatment choice across US nursing homes. J Clin Psychopharmacol (2012) 0.99
Evaluation of Selection Bias in an Internet-based Study of Pregnancy Planners. Epidemiology (2016) 0.98
Exclusion of immortal person-time. Pharmacoepidemiol Drug Saf (2008) 0.98
Comparison of different approaches to confounding adjustment in a study on the association of antipsychotic medication with mortality in older nursing home patients. Am J Epidemiol (2011) 0.98
Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments. BMC Med Res Methodol (2012) 0.98
Use of the Asthma Control Questionnaire to predict future risk of asthma exacerbation. J Allergy Clin Immunol (2010) 0.97
Estimating the proportion of all observed birth defects occurring in pregnancies terminated by a second-trimester abortion. Epidemiology (2014) 0.96
Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rare treatment decisions. Pharmacoepidemiol Drug Saf (2012) 0.96
Apgar score and hospitalization for epilepsy in childhood: a registry-based cohort study. BMC Public Health (2006) 0.95
Effect of serum albumin and bilirubin on the risk of myocardial infarction (the Framingham Offspring Study). Am J Cardiol (2003) 0.94
Leukemia risk in children exposed to benzene and PM10 from vehicular traffic: a case-control study in an Italian population. Eur J Epidemiol (2012) 0.93
Epidural analgesia and risks of cesarean and operative vaginal deliveries in nulliparous and multiparous women. Matern Child Health J (2010) 0.93
Simple estimators of the intensity of seasonal occurrence. BMC Med Res Methodol (2008) 0.92
A population-based study of stimulant drug treatment of ADHD and academic progress in children. Pediatrics (2012) 0.91
Hospitalization rates and survival associated with COPD: a nationwide Danish cohort study. Lung (2010) 0.91
Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups. Arthritis Rheum (2008) 0.91
Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis. BMC Nephrol (2013) 0.90
An epidemiological study of hemodialysis patients based on the European Fresenius Medical Care hemodialysis network: results of the ARO study. Nephron Clin Pract (2010) 0.89
Relation between serum albumin and carotid atherosclerosis: the NHLBI Family Heart Study. Stroke (2003) 0.89
Seasonal variation in month of birth and diagnosis in children and adolescents with Hodgkin disease and non-Hodgkin lymphoma. J Pediatr Hematol Oncol (2003) 0.89
Field test results of the motherhood method to measure maternal mortality. Indian J Med Res (2011) 0.88
Incidence of IBS in a cohort of people with asthma. Dig Dis Sci (2007) 0.87
Health outcomes among patients receiving oseltamivir. Pharmacoepidemiol Drug Saf (2004) 0.87
Predictors of preconceptional folic acid or multivitamin supplement use: a cross-sectional study of Danish pregnancy planners. Clin Epidemiol (2012) 0.87
Pre-gravid oral contraceptive use and time to pregnancy: a Danish prospective cohort study. Hum Reprod (2013) 0.86
Pregnancy-associated hypertensive disorders and adult cognitive function among Danish conscripts. Am J Epidemiol (2009) 0.86
Loratadine during pregnancy and hypospadias. Epidemiology (2008) 0.86
Propensity score calibration in the absence of surrogacy. Am J Epidemiol (2012) 0.86
Abnormal bone and mineral metabolism in kidney transplant patients--a review. Am J Nephrol (2007) 0.85
Relationship between epoetin alfa dose and mortality: findings from a marginal structural model. Clin J Am Soc Nephrol (2009) 0.85
Correlates of menstrual cycle characteristics among nulliparous Danish women. Clin Epidemiol (2013) 0.84
Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis. Pharmacoepidemiol Drug Saf (2012) 0.84
Estimating recurrences prevented from using trastuzumab in HER-2/neu-positive adjuvant breast cancer in the United States. Cancer (2010) 0.84
Strong association between smoking and the risk of revision in a cohort study of patients with metal-on-metal total hip arthroplasty. J Orthop Res (2014) 0.84
Challenges in designing a national surveillance program for inflammatory bowel disease in the United States. Inflamm Bowel Dis (2014) 0.83
The relation between amyotrophic lateral sclerosis and inorganic selenium in drinking water: a population-based case-control study. Environ Health (2010) 0.83
Healthcare use and costs before and after parathyroidectomy in patients on dialysis. BMC Health Serv Res (2013) 0.83
IRBs and epidemiologic research: how inappropriate restrictions hamper studies. IRB (1985) 0.83
Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture. Obstet Gynecol (2013) 0.83
Maternal use of oral contraceptives during early pregnancy and risk of hypospadias in male offspring. Urology (2009) 0.82
Chromosomal anomalies among the offspring of women with gestational diabetes. Am J Epidemiol (2002) 0.82
Maternal asthma, preeclampsia and risk of hypospadias. Epidemiology (2005) 0.82
Short-term mortality of bacteraemia in elderly patients with haematological malignancies. Br J Haematol (2006) 0.82
Impact of mineral and bone disorder on healthcare resource use and associated costs in the European Fresenius medical care dialysis population: a retrospective cohort study. BMC Nephrol (2012) 0.82
Physical activity, stress, and self-reported upper respiratory tract infection. Med Sci Sports Exerc (2011) 0.82
Folate intake and the risk of neural tube defects: an estimation of dose-response. Epidemiology (2003) 0.82
Cost-effectiveness of cinacalcet in secondary hyperparathyroidism in the United States. J Med Econ (2012) 0.81
Febrile seizures and cognitive function in young adult life: a prevalence study in Danish conscripts. J Pediatr (2009) 0.81
Risk of birth defects associated with maternal pregestational diabetes. Eur J Epidemiol (2014) 0.81
Association of cinacalcet adherence and costs in patients on dialysis. J Med Econ (2011) 0.81
Family history of later-onset breast cancer, breast healthy behavior and invasive breast cancer among postmenopausal women: a cohort study. Breast Cancer Res (2010) 0.81
Caffeinated beverage and soda consumption and time to pregnancy. Epidemiology (2012) 0.81